Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

EG626215 Inhibitors

Ccdc196, a protein characterized by coiled-coil domains, plays a pivotal role in cellular processes, yet the specifics of its functions remain to be fully elucidated. The coiled-coil domains suggest a structural role, potentially involved in protein-protein interactions or cellular organization. Beyond structural considerations, Ccdc196's functional significance may extend to regulatory roles within intricate signaling networks. While the exact biological pathways and cellular processes governed by Ccdc196 remain elusive, its involvement in coiled-coil interactions suggests potential roles in signal transduction, cellular transport, or cytoskeletal organization. Understanding its precise functions is critical to unraveling the complexity of cellular processes influenced by this enigmatic protein.

The inhibition of Ccdc196 involves targeting specific signaling pathways and cellular mechanisms that indirectly modulate its activity. The identified compounds, outlined in the tabulated form, exert their influence through diverse mechanisms. For instance, inhibitors disrupting the RAF/MEK/ERK and PI3K-Akt signaling pathways may impact Ccdc196 by interfering with cascades that regulate its function. Additionally, bromodomain inhibitors and proteasome inhibitors represent alternative avenues for indirect inhibition, potentially altering gene expression and protein turnover associated with Ccdc196. The multifaceted nature of the inhibitors underscores the intricate regulatory network governing Ccdc196, emphasizing the need for further research to decipher its precise functions and the interplay with cellular processes. In summary, Ccdc196 stands as a molecular puzzle, and its inhibition requires a nuanced understanding of the intricate cellular pathways it influences.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

BEZ235

915019-65-7sc-364429
50 mg
$211.00
8
(1)

Dual PI3K/mTOR inhibitor affecting PI3K-Akt-mTOR signaling. BEZ235 inhibits PI3K and mTOR, indirectly influencing Ccdc196 by disrupting the PI3K-Akt-mTOR pathway, potentially modulating cellular processes associated with Ccdc196 function.

Ruxolitinib

941678-49-5sc-364729
sc-364729A
sc-364729A-CW
5 mg
25 mg
25 mg
$251.00
$500.00
$547.00
16
(1)

JAK1/2 inhibitor affecting JAK-STAT signaling. Ruxolitinib inhibits JAK1 and JAK2, indirectly influencing Ccdc196 by modulating the JAK-STAT pathway, potentially altering cellular processes associated with Ccdc196 function.